1. Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies
- Author
-
Eric Hachulla, Alexis Mathian, Luc Mouthon, Bertrand Dunogue, Benjamin Terrier, Adrien Lemaignen, Fabienne Coury-Lucas, Virginie Rieu, Hélène Chaussade, Aurélie Ruet, Jerome Hadjadj, Gregoire Martin de Fremont, Maelle le Besnerais, Hélène Chabrolles, Audrey Mirand, Anne Sophie L'Honneur, Nicolas Mélé, David Boutboul, Meryem Farhat, Mouna Lazrek, Sonia Burrel, Isabelle Schuffenecker, Karl Stefic, Marion Carrette, and Veronique Avettand-Fenoel
- Subjects
Medicine - Abstract
Objective Patients with X linked agammaglobulinemia are susceptible to enterovirus (EV) infections. Similarly, severe EV infections have been described in patients with impaired B-cell response following treatment with anti-CD20 monoclonal antibodies (mAbs), mostly in those treated for haematological malignancies. We aimed to describe severe EV infections in patients receiving anti-CD20 mAbs for immune-mediated inflammatory diseases (IMIDs).Methods Patients were included following a screening of data collected through the routine surveillance of EV infections coordinated by the National Reference Center and a review of the literature. Additionally, neutralising antibodies were assessed in a patient with chronic EV-A71 meningoencephalitis.Results Nine original and 17 previously published cases were retrieved. Meningoencephalitis (n=21/26, 81%) associated with EV-positive cerebrospinal fluid (n=20/22, 91%) was the most common manifestation. The mortality rate was high (27%). EV was the only causal agents in all reported cases. Patients received multiple anti-CD20 mAbs infusions (median 8 (5–10)), resulting in complete B-cell depletion and moderate hypogammaglobulinemia (median 4.9 g/L (4.3–6.7)), and had limited concomitant immunosuppressive treatments. Finally, in a patient with EV-A71 meningoencephalitis, a lack of B-cell response to EV was shown.Conclusion EV infection should be evoked in patients with IMIDs presenting with atypical organ involvement, especially meningoencephalitis. Anti-CD20 mAbs may lead to impaired B-cell response against EV, although an underlying primary immunodeficiency should systematically be discussed.
- Published
- 2024
- Full Text
- View/download PDF